Compile Data Set for Download or QSAR
Report error Found 336 Enz. Inhib. hit(s) with all data for entry = 12986
TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747772BDBM747772(2-(2-((7-(3-(aminomethyl)phenyl)-5-(hydroxymethyl)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747771BDBM747771(2,2'-((((7-(3-(aminomethyl)phenyl)benzofuran-2,5-d...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747972BDBM747972(2-(2-(5-(3-(aminomethyl)phenyl)benzofuran-3-carbox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747970BDBM747970(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747964BDBM747964(2-(2-((7-(3-(aminomethyl)phenyl)benzo[b]thiophen-2...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747963BDBM747963(ethyl 2-(2-((7-(3-(aminomethyl)phenyl)-5-fluoroben...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747961BDBM747961(2-(2-((7-(3-(aminomethyl)phenyl)-5-((2-(2-ethoxy-2...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747979BDBM747979(2-(2-((5-(3-(aminomethyl)-2-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747978BDBM747978(2-(2-((3-(3-(aminomethyl)phenyl)benzofuran-5-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747977BDBM747977(2-(2-((7-(3-(aminomethyl)phenyl)-2-((2-(2-(tert-bu...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747976BDBM747976(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747975BDBM747975(2-(2-((7-(3-(aminomethyl)phenyl)-5-(((cyclopropylm...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747974BDBM747974(2-(2-((7-(3-(aminomethyl)phenyl)-5-(methoxycarbony...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747973BDBM747973(2-(2-((5-(3-(aminomethyl)-2-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747838BDBM747838(2-(2-((7-(3-(aminomethyl)phenyl)-2-(2-(2-(carboxym...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747829BDBM747829(2-(3-((5-(3-(aminomethyl)-2-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747821BDBM747821(2-(2-((7-(3-(aminomethyl)phenyl)benzofuran-2-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747779BDBM747779(2-(2-((5-(3-(aminomethyl)-2-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747775BDBM747775(2-(2-((7-(3-(aminomethyl)phenyl)-5-(phenoxymethyl)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747774BDBM747774(2,2'-((((7-(3-(aminomethyl)-2-fluorophenyl)benzofu...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747773BDBM747773(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747896BDBM747896(2-(2-((5-(3-(aminomethyl)-5-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747894BDBM747894(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747871BDBM747871(2-(2-((5,7-bis(3-(aminomethyl)phenyl)benzofuran-2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747869BDBM747869(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748004BDBM748004(2-(2-((5-(2-(aminomethyl)-3-fluoropyridin-4-yl)ben...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748003BDBM748003(2-(2-((5-(3-(aminomethyl)phenyl)-2-(tert-butoxycar...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748002BDBM748002(2-(2-((5-(3-(aminomethyl)phenyl)-6-methoxybenzofur...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748000BDBM748000(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747999BDBM747999(2-(2-((5-(3-(aminomethyl)phenyl)benzo[b]thiophen-3...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747998BDBM747998(2-(2-((7-(3-(aminomethyl)phenyl)-5-((cyclopropylme...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747997BDBM747997(2-(2-((5-(3-(aminomethyl)-2-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748012BDBM748012(2-(4-amino-2-((5-(3-(aminomethyl)phenyl)benzofuran...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748011BDBM748011(5-(3-(aminomethyl)phenyl)-3-((2-(carboxymethyl)-5-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748010BDBM748010((S)-2-(2-((5-(3-(1-amino-2-hydroxyethyl)phenyl)ben...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748009BDBM748009(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748007BDBM748007(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 748006BDBM748006(2-(2-((5-(3-(aminomethyl)phenyl)-7-((dimethylamino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747988BDBM747988(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)metho...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747987BDBM747987(2-(3-((7-(3-(aminomethyl)phenyl)-2-((2-(carboxymet...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747986BDBM747986(2-(2-((4-(3-(aminomethyl)phenyl)benzofuran-2-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747985BDBM747985(2-(2-((5-(3-(aminomethyl)phenyl)benzofuran-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747984BDBM747984(3-(2-((7-(3-(aminomethyl)phenyl)-2-((2-(carboxymet...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747983BDBM747983(2,2'-((((7-(2-(aminomethyl)pyridin-4-yl)benzofuran...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747982BDBM747982(2-(2-((5-(3-(aminomethyl)-2-fluorophenyl)benzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747981BDBM747981(2-(2-(5-(3-(aminomethyl)phenyl)-1H-pyrrolo[3,2-b]p...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747996BDBM747996(2-(2-((5-(3-(aminomethyl)phenyl)-7-methoxybenzofur...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747995BDBM747995(2-(2-((7-(3-(aminomethyl)phenyl)-5-fluorobenzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747993BDBM747993(2-(2-((5-(3-(aminomethyl)phenyl)-7-methylbenzofura...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetComplement factor D(Human)
Biocryst Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 747990BDBM747990(2-(2-((7-(3-(aminomethyl)phenyl)naphthalen-1-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, the compounds were dissolved in a stock solution of DMSO at 10.0 or 100 mM. A portion of this stock solution was added to assay buffer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 336 total ) | Next | Last >>
Jump to: